From the SCRS Team
February is American Heart Month, a time to be aware of the importance of heart health. SCRS is joining the annual movement by sharing insights into cardiovascular disease, research and treatment from different perspectives.
Women are more likely to go undiagnosed with heart disease than men, as they usually experience more subtle symptoms. Unfortunately, this often results in heart disease being recognized too late. Understanding the signs and symptoms of heart disease can be critical to early diagnosis and successful treatment. Listen to Diana Reedie’s moving story in the SCRS Talks podcast also featuring Vivienne van de Walle as they discuss the importance of being aware and advocating for your own heart health from both doctor and patient viewpoints.
We also spoke with Dr. Michael Koren, Medical Director and CEO of ENCORE Research Group, who provides his insights on how cardiovascular research and treatment have progressed over the past years, while giving an overview of the exciting new learnings in this essential therapeutic field. Additionally, he offers tips on how to maintain heart health, especially for busy professionals working in the demanding fields of healthcare and research. Listen to both of these SCRS Talks podcast episodes below!
Next month we are excited to host the Diversity and Global Oncology Site Solutions Summits in Austin, Texas March 30 – April 1. Each Summit will feature 1.5 days of invaluable learning, networking, and collaborative, solution-focused dialogue. Join us in Austin to be a part of these important discussions while gaining best practices, inspiration and actionable takeaways for your organization.
Building on the momentum of the inaugural Diversity Summit last year, SCRS has added another half day to this Summit to now to include breakouts, additional sessions and more networking opportunities. Significant action has been taken to increase access to clinical trials for underrepresented communities, and the Summit will highlight the progress we’ve made as an industry and how we can continue enacting change. We’ll explore recent regulatory directives, patient stories and data from the new Diversity Landscape Survey, among many other topics. The survey is open to all industry stakeholders, so please ensure your voice is heard.
The Global Oncology Summit will also feature prominent voices in oncology research that will discuss patient perspectives and practical insights into challenges oncology sites are facing today. If your site participates in oncology research, please take a few minutes to fill out the Oncology Micro Landscape Survey so SCRS can better advocate on your behalf.
SCRS has recently released several new resources available for the site community including a Phase 1 Oncology Resource for sites interested in conducting oncology research. The document, created by the SCRS Oncology committee, outlines several major considerations a site should explore when considering Phase 1 oncology trials.
The Digital Innovation Initiative also developed a Best Practices and Recommendations for Site Participation in Decentralized Trials (DCT) guide to help create a simpler and more streamlined user experience for sites participating in DCTs. This publication serves as a reference as sites begin to operate hybrid trials so they can most efficiently assess their own capabilities and gaps.
Additionally, a Site Invoiceables Toolkit was created to help sites better understand common billable items that a site should consider when assessing costs associated with a clinical trial. As a supplement to this resource, the Invoiceables Calculation Spreadsheet helps calculate the items described in the Site Invoiceables Guide. Both resources are designed to help guide and provide insight into common costs for conducting clinical trials. While the Site Invoiceables Guide is available to everyone, the Invoiceables Calculation Spreadsheet is exclusively for SCRS members.
We have many more exciting announcements, initiatives and programming in the works for 2023 and we can’t wait to share them with you. If you’d like to get involved with SCRS initiatives or feature your organization’s work in a publication, please reach out to firstname.lastname@example.org.
8 Insights From 9,000+ Real Clinical Trial Participant Surveys
By Velocity Clinical Research Clinical trials — especially high-volume trials — are primarily designed to collect quantitative data. Collecting and reviewing qualitative data and experiential feedback […]
Diversity Beyond Quotas: Intersectionality, Authenticity and Respect
By Rachel Baldwin, Associate Product Marketing Manager, Teckro When it comes to the importance of diversity, equity and inclusion (DEI), we all welcome the acceleration in […]
Prepare to Start Saying Goodbye to EDC Systems: Transitioning to Direct Data Capture is Inevitable
By Clinical ink Technologies come and technologies go. But how do you know when it’s time to abandon a familiar system for the latest innovation – […]
Operational Efficiencies in Clinical Research Begin with Site & Patient Experiences
By Queen Adaugo Ohandjo, Ph.D, MSCR Founder, Proof Clinical ResearchSite & Patient Experience Advocate Operational efficiencies, when properly leveraged, are a key opportunity in clinical research […]
Clinical Trial Technology: Top 5 Considerations for Training Site Staff
By Andrew Gerrard, Product Trainer, Greenphire, the global leader in financial lifecycle management for clinical trials. At the 2022 SCRS Global Summit, I had the opportunity […]
Merck’s Response to SCRS Open Letter to Industry
In Response to the Open Letter to Sponsor and CRO Colleagues Regarding the Workforce Retention and Inflationary Pressures Affecting Clinical Trial Sites As a large sponsor […]
SCRS Talks Podcast
Regional Meetings Update
A Reminder to Share SCRS Benefits With Every Team Member
Latest News from SCRS
SCRS Welcomes Takeda as Global Impact Partner
May 25, 2023 – The Society for Clinical Research Sites (SCRS) announced today that Takeda has joined the organization as a Global Impact Partner (GIP). The […]
SCRS Announces New Additions to Its Leadership Council
May 10, 2023 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today […]
SCRS Welcomes DM Clinical Research as Global Impact Partner
April 17, 2023– The Society for Clinical Research Sites (SCRS) today announced a Global Impact Partnership with DM Clinical Research, a growing and diverse site network […]
We’ll See You at These Upcoming Events!
ACCC Annual Meeting & Cancer Center Business Summit
March 8 – 10, 2023
SCRS Diversity & Global Oncology Site Solutions Summits
March 31 – April 1, 2023
Founded in 2012, SCRS is a global trade organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, connectivity and mentorship. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community.